Papers: 4 Apr 2014 - 11 Apr 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick A comparative study of experimental mouse models of central nervous system demyelination. Dumitrascu OM, Mott KR, Ghiasi H Gene Ther. 2014 Apr 10. PMID: 24718267. Abstract Editors' Pick Low testosterone is associated with disability in men with multiple sclerosis. Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller K, Chitnis T Mult Scler. 2014 Apr 7. Epub 1969 Dec 31. PMID: 24710799. Abstract Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program. Chen C-H, Kularatna G, Stone CD, Gutierrez AM, Dassopoulos T Ann Gastroenterol. 2013; 26(3):189-190. PMID: 24714228. Abstract Evaluation of brainstem involvement in multiple sclerosis. Krbot Skorić M, Adamec I, Nesek Mađarić V, Habek M Can J Neurol Sci. 2014 May; 41(3):346-9. PMID: 24718819. Abstract A history of multiple sclerosis investigations in Canada between 1850 and 1950. Ganesh A, Stahnisch FW Can J Neurol Sci. 2014 May; 41(3):320-32. PMID: 24718817. Abstract Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome. Heinz C, Schoonbrood S, Heiligenhaus A Br J Ophthalmol. 2014 Apr 8. PMID: 24713505. Abstract Emotional and neutral verbal memory impairment in Multiple Sclerosis. Iaffaldano P, Viterbo R G, Goretti B, Portaccio E, Amato M P, Trojano M J Neurol Sci. 2014 Mar 26. PMID: 24713509. Abstract The Relationship Between Familial Mediterranean Fever Gene (MEFV) Mutations and Clinical and Radiological Parameters in Multiple Sclerosis Patients. Terzi M, Taskın E, Unal Akdemir N, Bagcı H, Onar M Int J Neurosci. 2014 Apr 9. PMID: 24712487. Abstract Regulatory T cells in autoimmune neuroinflammation. Kleinewietfeld M, Hafler DA Immunol Rev. 2014 May; 259(1):231-44. PMID: 24712469. Abstract Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. Røsjø E, Myhr K-M, Løken-Amsrud K I, Bakke S J, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, et al. J Neuroimmunol. 2014 Mar 24. PMID: 24713402. Abstract Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis. Yousefi B, Ahmadi Y, Ghorbanihaghjo A, Faghfoori Z, Irannejad V S Biol Trace Elem Res. 2014 Apr 10. Epub 2014 Apr 10. PMID: 24715660. Abstract Complex assessment in progressive multiple sclerosis: a case report. Neamţu M C, Rusu L, Neamţu O M, Dănciulescu Miulescu R, Marin M I Rom J Morphol Embryol. 2014; 55(1):197-202. PMID: 24715188. Abstract Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases. Siritho S, Apiwattanakul M, Nakashima I, Takahashi T, Fujihara K, Prayoonwiwat N J Neurol Sci. 2014 Mar 25. PMID: 24713508. Abstract In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195. Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L J Nucl Med. 2014 Apr 7. PMID: 24711650. Abstract Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis. Turner AP, Sloan AP, Kivlahan DR, Haselkorn JK Rehabil Psychol. 2014 Apr 7. PMID: 24708232. Abstract Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue. Dung Dung A A, Panda A K BMJ Case Rep. 2014; 2014. PMID: 24711465. Abstract The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability. Moliné-Velázquez V, Ortega M C, Vila Del Sol V, Melero-Jerez C, de Castro F, Clemente D Neurobiol Dis. 2014 Apr 5. PMID: 24709559. Abstract Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales. Sonder JM, Balk LJ, Bosma LVAE, Polman CH, Uitdehaag B M Mult Scler. 2014 Apr 7. PMID: 24710798. Abstract Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease. Cusick MF, Libbey JE, Trede NS, Fujinami RS PLoS One. 2014; 9(4):e94486. Epub 2014 Apr 09. PMID: 24718491. Abstract Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study. Loitfelder M, Fazekas F, Koschutnig K, Fuchs S, Petrovic K, Ropele S, Pichler A, Jehna M, Langkammer C, Schmidt R, et al. PLoS One. 2014; 9(4):e93715. Epub 2014 Apr 09. PMID: 24718105. Abstract Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration. Holmes WR, Nie Q Biophys J. 2014 Apr 1; 106(7):1528-36. PMID: 24703314. Abstract A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis. Hildebrandt H, Eling P J Clin Exp Neuropsychol. 2014 Apr 7. PMID: 24702275. Abstract Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices. Baumstarck K, Boucekine M, Boyer L, Aghababian V, Parola N, Reuter F, Loundou A, Lançon C, Pelletier J, Auquier P BMC Neurol. 2014; 14(1):78. Epub 2014 Apr 08. PMID: 24708665. Abstract Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis. Kalman B, Toldy E Neuromolecular Med. 2014 Apr 8. Epub 2014 Apr 08. PMID: 24711208. Abstract [Therapeutic use of cannabis derivatives]. Benyamina A, Reynaud M Rev Prat. 2014 Feb; 64(2):165-8. PMID: 24701869. Abstract The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis. Trager N, Butler JT, Haque A, Ray SK, Beeson C, Banik NL J Clin Cell Immunol. 2013 Jun 14; 4(4):1000153. PMID: 24707444. Abstract 2014 multiple sclerosis therapeutic update. Cree BAC Neurohospitalist. 2014 Apr; 4(2):63-5. PMID: 24707333. Abstract Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders. Xiao M, Hu G CNS Neurosci Ther. 2014 May; 20(5):385-90. Epub 2014 Apr 08. PMID: 24712483. Abstract Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis. Sandroff BM, Motl RW, Pilutti LA, Learmonth YC, Ensari I, Dlugonski D, Klaren RE, Balantrapu S, Riskin BJ PLoS One. 2014; 9(4):e93511. Epub 2014 Apr 08. PMID: 24714028. Abstract Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors in T cell subsets. Mohammadzadeh A, Pourfathollah A A, Shahrokhi S, Hashemi S M, Moradi S L A, Soleimani M Int Immunopharmacol. 2014 Apr 2. PMID: 24704622. Abstract Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability. Neumann M, Sterr A, Claros-Salinas D, Gütler R, Ulrich R, Dettmers C J Neurol Sci. 2014 Mar 18. PMID: 24703580. Abstract Bilateral Surgical Reconstruction for Internal Jugular Veins Disease in Patients With Chronic Cerebrospinal Venous Insufficiency and associated Multiple Sclerosis. Spagnolo S, Scalise F, Barbato L, Grasso M A, Tesler UF Ann Vasc Surg. 2014 Apr 1. PMID: 24704584. Abstract Dextromethorphan/Quinidine for the treatment of pseudobulbar affect. Patatanian E, Casselman J Consult Pharm. 2014 Apr 1; 29(4):264-9. PMID: 24704895. Abstract Costs of multiple sclerosis - extrapolation of Czech data to Polish patients. Szmurło D, Fundament T, Ziobro M, Kruntorádová K, Doležal T, Głogowski C Expert Rev Pharmacoecon Outcomes Res. 2014 Apr 7. PMID: 24702130. Abstract Myelin proteomics: the past, the unexpected and the future. Panfoli I, Bruschi M, Santucci L, Calzia D, Ravera S, Petretto A, Candiano G Expert Rev Proteomics. 2014 Apr 4. PMID: 24702188. Abstract Janus Faces of Amyloid Proteins in Neuroinflammation. Steinman L, Rothbard JB, Kurnellas MP J Clin Immunol. 2014 Apr 8. Epub 2014 Apr 08. PMID: 24711007. Abstract BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis. Fujihara K J Neurol Neurosurg Psychiatry. 2014 Apr 4. PMID: 24706944. Abstract Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place? Wattjes MP, Vennegoor A, Mostert J, van Oosten BW, Barkhof F, Killestein J J Neurol. 2014 Apr 6. Epub 2014 Apr 06. PMID: 24705790. Abstract Internet-delivered lifestyle physical activity intervention improves body composition in multiple sclerosis: Preliminary evidence from a randomized controlled trial. Pilutti LA, Dlugonski D, Sandroff BM, Klaren RE, Motl RW Arch Phys Med Rehabil. 2014 Mar 31. PMID: 24699237. Abstract The detection of THC, CBD and CBN in the oral fluid of Sativex(®) patients using two on-site screening tests and LC-MS/MS. Molnar A, Fu S, Lewis J, Allsop DJ, Copeland J Forensic Sci Int. 2014 Mar 12; 238C:113-119. PMID: 24699310. Abstract Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models. Mangano K, Fagone P, Bendtzen K, Meroni P L, Quattrocchi C, Mammana S, Rosa M D, Malaguarnera L, Coco M, Magro G, et al. J Cell Physiol. 2014 Apr 2. PMID: 24700487. Abstract Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome? Renaud M, Aupy J, Uring-Lambert B, Chanson J-B, Collongues N, Blanc F, De Sèze J Eur J Neurol. 2014 Apr 2. PMID: 24698178. Abstract Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions. Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala Y, Botteman M Int J Clin Pract. 2014 Apr 2. PMID: 24698515. Abstract Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. Zhang H, Verkman AS J Autoimmun. 2014 Mar 31. PMID: 24698947. Abstract Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis. Warntjes JBM, Tisell A, Landtblom A-M, Lundberg P AJNR Am J Neuroradiol. 2014 Apr 3. PMID: 24699093. Abstract Simple MRI Metrics Contribute to Optimal Care of the Patient with Multiple Sclerosis. Simon JH, Bermel RA, Rudick RA AJNR Am J Neuroradiol. 2014 Apr 3. PMID: 24699092. Abstract [The process of meaning-making in adjustment to multiple sclerosis.] Couture C, Brassard A, Brault-Labbé A Rev Neurol (Paris). 2014 Mar 31. PMID: 24698035. Abstract Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS. Alvarenga-Filho H, Papais-Alvarenga R M, Carvalho S R, Clemente H N, Vasconcelos C C, Dias R M Int J Neurosci. 2014 Apr 3. PMID: 24697509. Abstract Acute disseminated encephalomyelitis mimicking acute meningoencephalitis. Ashrafi M R, Amirkashani D, Hirbod-Mobarakeh A, Yaghmaei B, Tavassoli A, Manafi F, Rezaei N Acta Clin Croat. 2013 Dec; 52(4):523-8. PMID: 24697005. Abstract The role of complementary and alternative medicine in therapy of multiple sclerosis. Kes V B, Cesarik M, Matovina L Z, Zavoreo I, Corić L, Drnasin S, Demarin V Acta Clin Croat. 2013 Dec; 52(4):464-71. PMID: 24696997. Abstract Objective and subjective measures reflect different aspects of balance in multiple sclerosis. Cameron MH, Huisinga J J Rehabil Res Dev. 2014 Feb; 50(10):1401-10. PMID: 24699975. Abstract Measurement characteristics and clinical utility of the 29-item Multiple Sclerosis Impact Scale. Widener GL, Allen DD Arch Phys Med Rehabil. 2014 Mar; 95(3):593-4. PMID: 24701634. Abstract Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients. Hoepner R, Ahlbrecht J, Faissner S, Schneider R, Dahlhaus S, Adams O, Raab P, Lukas C, Chan A, Stangel M, et al. J Neurol Neurosurg Psychiatry. 2014 Apr 3. PMID: 24700881. Abstract Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment. Fukumoto K, Mizoguchi H, Takeuchi H, Horiuchi H, Kawanokuchi J, Jin S, Mizuno T, Suzumura A Behav Brain Res. 2014 Jul 15; 268:88-93. Epub 2014 Apr 05. PMID: 24713151. Abstract Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Lin C-C, Bradstreet TR, Schwarzkopf EA, Sim J, Carrero JA, Chou C, Cook LE, Egawa T, Taneja R, Murphy TL, et al. Nat Commun. 2014; 5:3551. PMID: 24699451. Abstract Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis. Jiang Z, Jiang JX, Zhang G-X Immunol Lett. 2014 Mar 31; 160(1):17-22. PMID: 24698730. Abstract Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity. Bellavance M-A, Gosselin D, Yong WV, Stys PK, Rivest S Brain Struct Funct. 2014 Apr 5. Epub 2014 Apr 05. PMID: 24706067. Abstract Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis. Hanumanthaiah D, Ramanathan K Indian J Crit Care Med. 2014 Mar; 18(3):178-80. PMID: 24701071. Abstract Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, et al. Ann Neurol. 2014 Feb 11. PMID: 24700511. Abstract Correction: Combined Acquisition Technique (CAT) for Neuroimaging of Multiple Sclerosis at Low Specific Absorption Rates (SAR). PLOS ONE Staff PLoS One. 2014; 9(4):e94439. Epub 2014 Apr 04. PMID: 24705514. Abstract The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis. Fox E, Green B, Markowitz C, Murray R, Goodman AD, Glenski SJ, Loupe P, Cogburn J N BMC Neurol. 2014; 14(1):73. Epub 2014 Apr 04. PMID: 24708578. Abstract A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome. Gnanapavan S, Jaunmuktane Z, Baruteau K P, Gnanasambandam S, Schmierer K BMC Neurol. 2014; 14(1):68. Epub 2014 Apr 02. PMID: 24694183. Abstract Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis. Ruggieri S, Tortorella C, Gasperini C Ther Clin Risk Manag. 2014; 10:229-239. Epub 2014 Mar 27. PMID: 24707183. Abstract Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Ridderstad Wollberg A, Ericsson-Dahlstrand A, Juréus A, Ekerot P, Simon S, Nilsson M, Wiklund S-J, Berg A-L, Ferm M, Sunnemark D, et al. Proc Natl Acad Sci U S A. 2014 Apr 8; 111(14):5409-14. Epub 2014 Mar 25. PMID: 24706865. Abstract The Dopaminergic System in Autoimmune Diseases. Pacheco R, Contreras F, Zouali M Front Immunol. 2014; 5:117. Epub 2014 Mar 21. PMID: 24711809. Abstract Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. Tanaka M, Tanaka K J Neuroimmunol. 2014 May 15; 270(1-2):98-9. Epub 2014 Mar 11. PMID: 24703097. Abstract
Editors' Pick A comparative study of experimental mouse models of central nervous system demyelination. Dumitrascu OM, Mott KR, Ghiasi H Gene Ther. 2014 Apr 10. PMID: 24718267. Abstract
Editors' Pick Low testosterone is associated with disability in men with multiple sclerosis. Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller K, Chitnis T Mult Scler. 2014 Apr 7. Epub 1969 Dec 31. PMID: 24710799. Abstract
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program. Chen C-H, Kularatna G, Stone CD, Gutierrez AM, Dassopoulos T Ann Gastroenterol. 2013; 26(3):189-190. PMID: 24714228. Abstract
Evaluation of brainstem involvement in multiple sclerosis. Krbot Skorić M, Adamec I, Nesek Mađarić V, Habek M Can J Neurol Sci. 2014 May; 41(3):346-9. PMID: 24718819. Abstract
A history of multiple sclerosis investigations in Canada between 1850 and 1950. Ganesh A, Stahnisch FW Can J Neurol Sci. 2014 May; 41(3):320-32. PMID: 24718817. Abstract
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome. Heinz C, Schoonbrood S, Heiligenhaus A Br J Ophthalmol. 2014 Apr 8. PMID: 24713505. Abstract
Emotional and neutral verbal memory impairment in Multiple Sclerosis. Iaffaldano P, Viterbo R G, Goretti B, Portaccio E, Amato M P, Trojano M J Neurol Sci. 2014 Mar 26. PMID: 24713509. Abstract
The Relationship Between Familial Mediterranean Fever Gene (MEFV) Mutations and Clinical and Radiological Parameters in Multiple Sclerosis Patients. Terzi M, Taskın E, Unal Akdemir N, Bagcı H, Onar M Int J Neurosci. 2014 Apr 9. PMID: 24712487. Abstract
Regulatory T cells in autoimmune neuroinflammation. Kleinewietfeld M, Hafler DA Immunol Rev. 2014 May; 259(1):231-44. PMID: 24712469. Abstract
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. Røsjø E, Myhr K-M, Løken-Amsrud K I, Bakke S J, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, et al. J Neuroimmunol. 2014 Mar 24. PMID: 24713402. Abstract
Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis. Yousefi B, Ahmadi Y, Ghorbanihaghjo A, Faghfoori Z, Irannejad V S Biol Trace Elem Res. 2014 Apr 10. Epub 2014 Apr 10. PMID: 24715660. Abstract
Complex assessment in progressive multiple sclerosis: a case report. Neamţu M C, Rusu L, Neamţu O M, Dănciulescu Miulescu R, Marin M I Rom J Morphol Embryol. 2014; 55(1):197-202. PMID: 24715188. Abstract
Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases. Siritho S, Apiwattanakul M, Nakashima I, Takahashi T, Fujihara K, Prayoonwiwat N J Neurol Sci. 2014 Mar 25. PMID: 24713508. Abstract
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195. Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L J Nucl Med. 2014 Apr 7. PMID: 24711650. Abstract
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis. Turner AP, Sloan AP, Kivlahan DR, Haselkorn JK Rehabil Psychol. 2014 Apr 7. PMID: 24708232. Abstract
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue. Dung Dung A A, Panda A K BMJ Case Rep. 2014; 2014. PMID: 24711465. Abstract
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability. Moliné-Velázquez V, Ortega M C, Vila Del Sol V, Melero-Jerez C, de Castro F, Clemente D Neurobiol Dis. 2014 Apr 5. PMID: 24709559. Abstract
Do patient and proxy agree? Long-term changes in multiple sclerosis physical impact and walking ability on patient-reported outcome scales. Sonder JM, Balk LJ, Bosma LVAE, Polman CH, Uitdehaag B M Mult Scler. 2014 Apr 7. PMID: 24710798. Abstract
Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease. Cusick MF, Libbey JE, Trede NS, Fujinami RS PLoS One. 2014; 9(4):e94486. Epub 2014 Apr 09. PMID: 24718491. Abstract
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study. Loitfelder M, Fazekas F, Koschutnig K, Fuchs S, Petrovic K, Ropele S, Pichler A, Jehna M, Langkammer C, Schmidt R, et al. PLoS One. 2014; 9(4):e93715. Epub 2014 Apr 09. PMID: 24718105. Abstract
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration. Holmes WR, Nie Q Biophys J. 2014 Apr 1; 106(7):1528-36. PMID: 24703314. Abstract
A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis. Hildebrandt H, Eling P J Clin Exp Neuropsychol. 2014 Apr 7. PMID: 24702275. Abstract
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices. Baumstarck K, Boucekine M, Boyer L, Aghababian V, Parola N, Reuter F, Loundou A, Lançon C, Pelletier J, Auquier P BMC Neurol. 2014; 14(1):78. Epub 2014 Apr 08. PMID: 24708665. Abstract
Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis. Kalman B, Toldy E Neuromolecular Med. 2014 Apr 8. Epub 2014 Apr 08. PMID: 24711208. Abstract
[Therapeutic use of cannabis derivatives]. Benyamina A, Reynaud M Rev Prat. 2014 Feb; 64(2):165-8. PMID: 24701869. Abstract
The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis. Trager N, Butler JT, Haque A, Ray SK, Beeson C, Banik NL J Clin Cell Immunol. 2013 Jun 14; 4(4):1000153. PMID: 24707444. Abstract
2014 multiple sclerosis therapeutic update. Cree BAC Neurohospitalist. 2014 Apr; 4(2):63-5. PMID: 24707333. Abstract
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders. Xiao M, Hu G CNS Neurosci Ther. 2014 May; 20(5):385-90. Epub 2014 Apr 08. PMID: 24712483. Abstract
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis. Sandroff BM, Motl RW, Pilutti LA, Learmonth YC, Ensari I, Dlugonski D, Klaren RE, Balantrapu S, Riskin BJ PLoS One. 2014; 9(4):e93511. Epub 2014 Apr 08. PMID: 24714028. Abstract
Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors in T cell subsets. Mohammadzadeh A, Pourfathollah A A, Shahrokhi S, Hashemi S M, Moradi S L A, Soleimani M Int Immunopharmacol. 2014 Apr 2. PMID: 24704622. Abstract
Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability. Neumann M, Sterr A, Claros-Salinas D, Gütler R, Ulrich R, Dettmers C J Neurol Sci. 2014 Mar 18. PMID: 24703580. Abstract
Bilateral Surgical Reconstruction for Internal Jugular Veins Disease in Patients With Chronic Cerebrospinal Venous Insufficiency and associated Multiple Sclerosis. Spagnolo S, Scalise F, Barbato L, Grasso M A, Tesler UF Ann Vasc Surg. 2014 Apr 1. PMID: 24704584. Abstract
Dextromethorphan/Quinidine for the treatment of pseudobulbar affect. Patatanian E, Casselman J Consult Pharm. 2014 Apr 1; 29(4):264-9. PMID: 24704895. Abstract
Costs of multiple sclerosis - extrapolation of Czech data to Polish patients. Szmurło D, Fundament T, Ziobro M, Kruntorádová K, Doležal T, Głogowski C Expert Rev Pharmacoecon Outcomes Res. 2014 Apr 7. PMID: 24702130. Abstract
Myelin proteomics: the past, the unexpected and the future. Panfoli I, Bruschi M, Santucci L, Calzia D, Ravera S, Petretto A, Candiano G Expert Rev Proteomics. 2014 Apr 4. PMID: 24702188. Abstract
Janus Faces of Amyloid Proteins in Neuroinflammation. Steinman L, Rothbard JB, Kurnellas MP J Clin Immunol. 2014 Apr 8. Epub 2014 Apr 08. PMID: 24711007. Abstract
BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis. Fujihara K J Neurol Neurosurg Psychiatry. 2014 Apr 4. PMID: 24706944. Abstract
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place? Wattjes MP, Vennegoor A, Mostert J, van Oosten BW, Barkhof F, Killestein J J Neurol. 2014 Apr 6. Epub 2014 Apr 06. PMID: 24705790. Abstract
Internet-delivered lifestyle physical activity intervention improves body composition in multiple sclerosis: Preliminary evidence from a randomized controlled trial. Pilutti LA, Dlugonski D, Sandroff BM, Klaren RE, Motl RW Arch Phys Med Rehabil. 2014 Mar 31. PMID: 24699237. Abstract
The detection of THC, CBD and CBN in the oral fluid of Sativex(®) patients using two on-site screening tests and LC-MS/MS. Molnar A, Fu S, Lewis J, Allsop DJ, Copeland J Forensic Sci Int. 2014 Mar 12; 238C:113-119. PMID: 24699310. Abstract
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models. Mangano K, Fagone P, Bendtzen K, Meroni P L, Quattrocchi C, Mammana S, Rosa M D, Malaguarnera L, Coco M, Magro G, et al. J Cell Physiol. 2014 Apr 2. PMID: 24700487. Abstract
Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome? Renaud M, Aupy J, Uring-Lambert B, Chanson J-B, Collongues N, Blanc F, De Sèze J Eur J Neurol. 2014 Apr 2. PMID: 24698178. Abstract
Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions. Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Desai P, Jalundhwala Y, Botteman M Int J Clin Pract. 2014 Apr 2. PMID: 24698515. Abstract
Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. Zhang H, Verkman AS J Autoimmun. 2014 Mar 31. PMID: 24698947. Abstract
Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis. Warntjes JBM, Tisell A, Landtblom A-M, Lundberg P AJNR Am J Neuroradiol. 2014 Apr 3. PMID: 24699093. Abstract
Simple MRI Metrics Contribute to Optimal Care of the Patient with Multiple Sclerosis. Simon JH, Bermel RA, Rudick RA AJNR Am J Neuroradiol. 2014 Apr 3. PMID: 24699092. Abstract
[The process of meaning-making in adjustment to multiple sclerosis.] Couture C, Brassard A, Brault-Labbé A Rev Neurol (Paris). 2014 Mar 31. PMID: 24698035. Abstract
Does fatigue occur in MS patients without disability? Suggested running head: Fatigue and disability in MS. Alvarenga-Filho H, Papais-Alvarenga R M, Carvalho S R, Clemente H N, Vasconcelos C C, Dias R M Int J Neurosci. 2014 Apr 3. PMID: 24697509. Abstract
Acute disseminated encephalomyelitis mimicking acute meningoencephalitis. Ashrafi M R, Amirkashani D, Hirbod-Mobarakeh A, Yaghmaei B, Tavassoli A, Manafi F, Rezaei N Acta Clin Croat. 2013 Dec; 52(4):523-8. PMID: 24697005. Abstract
The role of complementary and alternative medicine in therapy of multiple sclerosis. Kes V B, Cesarik M, Matovina L Z, Zavoreo I, Corić L, Drnasin S, Demarin V Acta Clin Croat. 2013 Dec; 52(4):464-71. PMID: 24696997. Abstract
Objective and subjective measures reflect different aspects of balance in multiple sclerosis. Cameron MH, Huisinga J J Rehabil Res Dev. 2014 Feb; 50(10):1401-10. PMID: 24699975. Abstract
Measurement characteristics and clinical utility of the 29-item Multiple Sclerosis Impact Scale. Widener GL, Allen DD Arch Phys Med Rehabil. 2014 Mar; 95(3):593-4. PMID: 24701634. Abstract
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients. Hoepner R, Ahlbrecht J, Faissner S, Schneider R, Dahlhaus S, Adams O, Raab P, Lukas C, Chan A, Stangel M, et al. J Neurol Neurosurg Psychiatry. 2014 Apr 3. PMID: 24700881. Abstract
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment. Fukumoto K, Mizoguchi H, Takeuchi H, Horiuchi H, Kawanokuchi J, Jin S, Mizuno T, Suzumura A Behav Brain Res. 2014 Jul 15; 268:88-93. Epub 2014 Apr 05. PMID: 24713151. Abstract
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Lin C-C, Bradstreet TR, Schwarzkopf EA, Sim J, Carrero JA, Chou C, Cook LE, Egawa T, Taneja R, Murphy TL, et al. Nat Commun. 2014; 5:3551. PMID: 24699451. Abstract
Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis. Jiang Z, Jiang JX, Zhang G-X Immunol Lett. 2014 Mar 31; 160(1):17-22. PMID: 24698730. Abstract
Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity. Bellavance M-A, Gosselin D, Yong WV, Stys PK, Rivest S Brain Struct Funct. 2014 Apr 5. Epub 2014 Apr 05. PMID: 24706067. Abstract
Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis. Hanumanthaiah D, Ramanathan K Indian J Crit Care Med. 2014 Mar; 18(3):178-80. PMID: 24701071. Abstract
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, et al. Ann Neurol. 2014 Feb 11. PMID: 24700511. Abstract
Correction: Combined Acquisition Technique (CAT) for Neuroimaging of Multiple Sclerosis at Low Specific Absorption Rates (SAR). PLOS ONE Staff PLoS One. 2014; 9(4):e94439. Epub 2014 Apr 04. PMID: 24705514. Abstract
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis. Fox E, Green B, Markowitz C, Murray R, Goodman AD, Glenski SJ, Loupe P, Cogburn J N BMC Neurol. 2014; 14(1):73. Epub 2014 Apr 04. PMID: 24708578. Abstract
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome. Gnanapavan S, Jaunmuktane Z, Baruteau K P, Gnanasambandam S, Schmierer K BMC Neurol. 2014; 14(1):68. Epub 2014 Apr 02. PMID: 24694183. Abstract
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis. Ruggieri S, Tortorella C, Gasperini C Ther Clin Risk Manag. 2014; 10:229-239. Epub 2014 Mar 27. PMID: 24707183. Abstract
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Ridderstad Wollberg A, Ericsson-Dahlstrand A, Juréus A, Ekerot P, Simon S, Nilsson M, Wiklund S-J, Berg A-L, Ferm M, Sunnemark D, et al. Proc Natl Acad Sci U S A. 2014 Apr 8; 111(14):5409-14. Epub 2014 Mar 25. PMID: 24706865. Abstract
The Dopaminergic System in Autoimmune Diseases. Pacheco R, Contreras F, Zouali M Front Immunol. 2014; 5:117. Epub 2014 Mar 21. PMID: 24711809. Abstract
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. Tanaka M, Tanaka K J Neuroimmunol. 2014 May 15; 270(1-2):98-9. Epub 2014 Mar 11. PMID: 24703097. Abstract